ZNF573 Activators
ZNF573 can involve a variety of mechanisms that modulate cellular signaling pathways, leading to an increase in ZNF573 activity through phosphorylation. Forskolin acts by directly stimulating adenylyl cyclase, which catalyzes the conversion of ATP to cAMP. The elevation of intracellular cAMP levels can activate protein kinase A (PKA), which subsequently phosphorylates target proteins such as ZNF573. IBMX, by inhibiting phosphodiesterases, prevents the degradation of cAMP and cGMP, thereby sustaining the activation of PKA and promoting the phosphorylation of ZNF573. Dibutyryl-cAMP, a cAMP analog, bypasses the need for adenylyl cyclase activation and directly stimulates PKA, leading to the phosphorylation of ZNF573. Okadaic Acid and Calyculin A, by inhibiting the protein phosphatases PP1 and PP2A, prevent the dephosphorylation of proteins within the cell, which can result in a net increase in the phosphorylated state of ZNF573.
In addition to these cAMP-related mechanisms, other chemical activators operate through different pathways. PMA activates protein kinase C (PKC), which phosphorylates a wide range of cellular targets, including ZNF573. Ionomycin and A23187 both act as calcium ionophores, increasing the intracellular calcium concentration and activating calcium-dependent kinases that can phosphorylate ZNF573. Anisomycin stimulates the Stress-Activated Protein Kinases (SAPKs) and p38 MAP kinase, leading to the phosphorylation of ZNF573 in response to stress signals. Chelerythrine and BIM, although primarily inhibitors of PKC, can indirectly cause activation of ZNF573 through alternative pathways that compensate for the inhibition of PKC. Similarly, Ro-31-8220, another PKC inhibitor, can lead to the activation of pathways resulting in the phosphorylation of ZNF573. These chemicals, by targeting different enzymes and pathways, demonstrate the multifaceted nature of cellular regulation and the diverse mechanisms by which ZNF573 can be activated.
SEE ALSO...
Items 1 to 10 of 11 total
Display:
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
IBMX | 28822-58-4 | sc-201188 sc-201188B sc-201188A | 200 mg 500 mg 1 g | $260.00 $350.00 $500.00 | 34 | |
IBMX is a nonspecific inhibitor of phosphodiesterases, which prevents the breakdown of cAMP and cGMP. Elevated levels of cAMP can activate protein kinase A (PKA), potentially resulting in the phosphorylation and subsequent activation of ZNF573. | ||||||
PMA | 16561-29-8 | sc-3576 sc-3576A sc-3576B sc-3576C sc-3576D | 1 mg 5 mg 10 mg 25 mg 100 mg | $41.00 $132.00 $214.00 $500.00 $948.00 | 119 | |
Phorbol 12-myristate 13-acetate (PMA) activates protein kinase C (PKC), which can lead to the phosphorylation of transcription factors and co-regulatory proteins. This PKC-mediated phosphorylation could activate ZNF573 by promoting its interaction with other proteins or DNA. | ||||||
Ionomycin | 56092-82-1 | sc-3592 sc-3592A | 1 mg 5 mg | $78.00 $270.00 | 80 | |
Ionomycin functions as a calcium ionophore, raising intracellular calcium levels, which can activate calcium-dependent protein kinases. These kinases, in turn, might phosphorylate and activate ZNF573 as part of a signaling cascade. | ||||||
A23187 | 52665-69-7 | sc-3591 sc-3591B sc-3591A sc-3591C | 1 mg 5 mg 10 mg 25 mg | $55.00 $131.00 $203.00 $317.00 | 23 | |
A23187 is another calcium ionophore that increases intracellular calcium concentration, potentially activating calmodulin-dependent protein kinases, which may phosphorylate and thus activate ZNF573. | ||||||
Dibutyryl-cAMP | 16980-89-5 | sc-201567 sc-201567A sc-201567B sc-201567C | 20 mg 100 mg 500 mg 10 g | $47.00 $136.00 $492.00 $4552.00 | 74 | |
Dibutyryl-cAMP is a cell-permeable cAMP analog that directly activates cAMP-dependent pathways, possibly leading to the activation of ZNF573 through phosphorylation by protein kinase A. | ||||||
Okadaic Acid | 78111-17-8 | sc-3513 sc-3513A sc-3513B | 25 µg 100 µg 1 mg | $291.00 $530.00 $1800.00 | 78 | |
Okadaic acid is an inhibitor of protein phosphatases PP1 and PP2A, leading to increased phosphorylation levels within the cell. This could result in the activation of ZNF573 by maintaining its phosphorylated state. | ||||||
Anisomycin | 22862-76-6 | sc-3524 sc-3524A | 5 mg 50 mg | $99.00 $259.00 | 36 | |
Anisomycin activates Stress-Activated Protein Kinases (SAPKs) and p38 MAP kinase, which can lead to the phosphorylation of a variety of proteins. This stress response could indirectly activate ZNF573 through a phosphorylation-dependent mechanism. | ||||||
Calyculin A | 101932-71-2 | sc-24000 sc-24000A | 10 µg 100 µg | $163.00 $800.00 | 59 | |
Calyculin A, similar to okadaic acid, is a potent inhibitor of protein phosphatases 1 and 2A, leading to hyperphosphorylation. This could enhance the phosphorylation and activation of ZNF573. | ||||||
Chelerythrine | 34316-15-9 | sc-507380 | 100 mg | $540.00 | ||
Chelerythrine is a selective inhibitor of protein kinase C. While it is primarily an inhibitor, it can paradoxically lead to the activation of certain downstream proteins due to compensatory cellular mechanisms, potentially including ZNF573. | ||||||
Brefeldin A | 20350-15-6 | sc-200861C sc-200861 sc-200861A sc-200861B | 1 mg 5 mg 25 mg 100 mg | $31.00 $53.00 $124.00 $374.00 | 25 | |
Bisindolylmaleimide I (BIM) is another PKC inhibitor which, through compensatory feedback mechanisms in the cell, may lead to the activation of alternative pathways that contribute to the activation of ZNF573. | ||||||